Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis
Authors:
- 1 June 1994
- journal article
- clinical trial
- Published by Springer Nature in Rheumatology International
- Vol. 14 (1) , 33-38
Abstract
The objective of the present study was to assess the rate of side-effects and dose-limiting toxicity in patients with rheumatoid arthritis (RA) receiving methotrexate (MTX) at an initial dose of 15 or 25 mg/week. One hundred and eighty-five patients with active RA were enrolled into a prospective non-blind trial over 12 months and randomized to start at a dose of 15 mg/week with subsequent increases if necessary (group A) or 25 mg/week with subsequent dose reductions according to effect (group B). With 168 patients eligible for evaluation 74% of patients in group A and 73% of patients in group B were on MTX after 12 months. Withdrawal due to side-effects amounted to 16% of patients in group A and 18% in group B, and decreases in dose due to side-effects amounted to 10% in group A and 9% in group B. The higher dose of MTX elicited a significantly higher rate of gastrointestinal side-effects (28% versus 17%, P<0.05) and a tendency towards a higher rate of liver enzyme elevations (47% versus 39%). The frequencies of other side-effects did not differ significantly between the groups. We concluded that starting MTX treatment at a dose of 25 mg/week was associated with a higher rate of minor but not major toxicity as compared with 15 mg/week. With this profile of tolerability it is possible to examine the therapeutic potential of MTX doses exceeding 15 mg/week.Keywords
This publication has 31 references indexed in Scilit:
- Retardation of Radiologic Progression in Rheumatoid Arthritis With Methotrexate Therapy. A Controlled StudyArthritis & Rheumatism, 1991
- Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty‐eight–week randomized, double‐blind trialArthritis & Rheumatism, 1991
- Low‐dose methotrexate compared with auranofin in adult rheumatoid arthritisArthritis & Rheumatism, 1990
- PROSPECTIVE LONG TERM FOLLOW-UP OF METHOTREXATE THERAPY IN RHEUMATOID ARTHRITIS: TOXICITY, EFFICACY AND RADIOLOGICAL PROGRESSIONRheumatology, 1989
- Liver histology in rheumatoid arthritis patients receiving long‐term methotrexate therapy. A Prospective Study with Baseline and Sequential Biopsy SamplesArthritis & Rheumatism, 1989
- Histopathologic findings in the liver of rheumatoid arthritis patients treated with long‐term bolus methotrexateArthritis & Rheumatism, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritisArchives of internal medicine (1960), 1985
- Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical TrialArthritis & Rheumatism, 1985
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985